In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
Reminder - Five CTS Forms will be updated on Monday September 2, 2019. Some of the forms are posted ...
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...